What one share of LeonaBio holds
We are a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (“ALS”), with the goal of improving patients’ lives.
LeonaBio’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$10.94 |
|---|---|
| Cash and investments | $3.43 |
| Book value | $3.57 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$14.47 | — | — | — | −$54.16 |
| 2020 | — | −$16.68 | $1.94 | −$22.09 | — | — |
| 2021 | — | −$14.86 | $0.43 | −$12.10 | — | $85.90 |
| 2022 | — | −$25.35 | $0.30 | −$19.51 | — | $62.08 |
| 2023 | — | −$30.95 | $0.08 | −$26.58 | — | $34.11 |
| 2024 | — | −$25.19 | $0.01 | −$25.26 | — | $11.49 |
| 2025 | — | −$24.70 | — | — | — | $2.98 |
Common questions about LeonaBio
How much does one share of LeonaBio earn?
Over the last 12 months, LeonaBio lost $10.94 for each share.
Does LeonaBio pay a dividend?
LeonaBio didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is LeonaBio’s book value per share?
LeonaBio’s book value is $3.57 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of LeonaBio have?
Each share of LeonaBio has $3.43 of cash and investments, as of June 30, 2026.
Has LeonaBio bought back shares?
LeonaBio’s share count rose about 1099% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.